OPC-41061

· Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for OPC-41061, covering 2013-12-25 to 2021-06-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects [Phase 1]

See pricing